Founded in 1973, Kivipharm HengCheng Ltd is a high-tech enterprise that spans multiple regions and integrates production, education, and research, specializing in drug research and development, production, and sales. Headquartered in Zhangjiakou, Hebei Province, the company has undergone over five decades of accumulation and development. Currently, it comprises Kivipharm Co., Ltd、Camfield Plant, Kivipharm Co., Ltd.、Kivipharm HengCheng Ltd、Hainan Hengcheng Pharmaceutical Technology Co.,Ltd.、Shanghai Kaiwei Pharmaceutical Technology Co., Ltd., and Gamland GmbH. The company currently holds 87 drug approval numbers, covering therapeutic areas such as emergency rescue, clinically essential and scarce drugs, rare diseases, respiratory diseases, cardiovascular and cerebrovascular diseases, and chronic diseases.
The company currently boasts production bases for small-volume injections, solid dosage forms, and active pharmaceutical ingredients (APIs), and has collaborated on CMO and CDMO R&D projects with numerous top 100 pharmaceutical companies. Since its inception, the company has been awarded numerous honorary titles, including Hebei High-tech Enterprise, Hebei Industrial Enterprise R&D Center A-level Base, Hebei International Pharmaceutical Innovation Technology Team, Hebei Postdoctoral Innovation Practice Base, and Hebei Major Scientific and Technological Achievements Transformation Base. The company adheres to a clinical needs-oriented approach, advancing the production of injections, solid dosage forms, and APIs in parallel. Its small-volume injection ampoule filling production line encompasses fully sterile filling and final sterilization filling, achieving technical difficulties up to the level of microgram content and filling volumes below 1 ml.
